97 related articles for article (PubMed ID: 25737072)
1. Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey.
Sauter M; Sigl J; Schotten KJ; Kreuzer L; Günthner-Biller M; Fischereder M
Int Urol Nephrol; 2015 Apr; 47(4):707-8. PubMed ID: 25737072
[No Abstract] [Full Text] [Related]
2. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
[TBL] [Abstract][Full Text] [Related]
3. [Clinical case of delayed diagnosis of tuberous sclerosis].
Alyaev YG; Shpot EV; Akopyan GN; Goryacheva KM; Chinenov DV; Gadzhieva ZK; Kodzokov MA; Damiev AD; Geleje PB
Urologiia; 2019 Dec; (6):98-105. PubMed ID: 32003176
[TBL] [Abstract][Full Text] [Related]
4. Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action.
Pirson Y
Nephrol Dial Transplant; 2013 Jul; 28(7):1680-5. PubMed ID: 23413089
[No Abstract] [Full Text] [Related]
5. [Renal angiomyolipoma and renal cell carcinoma associated with tuberous sclerosis: a case report].
Sugimoto M; Takamura S
Hinyokika Kiyo; 1997 Jan; 43(1):33-5. PubMed ID: 9046419
[TBL] [Abstract][Full Text] [Related]
6. Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: Resolution with Everolimus Treatment.
Lim KH; Silverstone EJ; Yates DH
Am J Respir Crit Care Med; 2020 May; 201(10):e76. PubMed ID: 31870163
[No Abstract] [Full Text] [Related]
7. mTOR inhibitors are the first-choice therapy for renal angiomyolipomas secondary to tuberous sclerosis.
Monich AG; Cunha MFMD; Barreto FC
J Bras Nefrol; 2023; 45(4):503-505. PubMed ID: 37497829
[No Abstract] [Full Text] [Related]
8. Bilateral renal angiomyolipoma in association with tuberous sclerosis.
Lanjewar DN; Jain P; Maheshwari MB; Setty CR
Indian J Pathol Microbiol; 1997 Jul; 40(3):405-7. PubMed ID: 9354019
[TBL] [Abstract][Full Text] [Related]
9. Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas.
Coombs EJ
J Am Assoc Nurse Pract; 2013 Nov; 25(11):588-96. PubMed ID: 24170533
[TBL] [Abstract][Full Text] [Related]
10. Renal lesion growth in children with tuberous sclerosis complex.
Ewalt DH; Sheffield E; Sparagana SP; Delgado MR; Roach ES
J Urol; 1998 Jul; 160(1):141-5. PubMed ID: 9628635
[TBL] [Abstract][Full Text] [Related]
11. Bilateral renal angiomyolipoma coexistent with pulmonary lymphangioleiomyomatosis and tuberous sclerosis.
Yoshida S; Hayashi T; Ishii N; Yoshinaga A; Ohno R; Terao T; Watanabe T; Yamada T; Osada H
Int Urol Nephrol; 2006; 38(3-4):413-5. PubMed ID: 17111084
[TBL] [Abstract][Full Text] [Related]
12. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: A clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification.
Nese N; Martignoni G; Fletcher CD; Gupta R; Pan CC; Kim H; Ro JY; Hwang IS; Sato K; Bonetti F; Pea M; Amin MB; Hes O; Svec A; Kida M; Vankalakunti M; Berel D; Rogatko A; Gown AM; Amin MB
Am J Surg Pathol; 2011 Feb; 35(2):161-76. PubMed ID: 21263237
[TBL] [Abstract][Full Text] [Related]
13. [Renal lesions in tuberous sclerosis].
Schillinger F; Montagnac R
Nephrol Ther; 2006 Jan; 2 Suppl 2():S123-6. PubMed ID: 17373212
[TBL] [Abstract][Full Text] [Related]
14. [Coincident renal cell carcinoma and renal angiomyolipoma in tuberous sclerosis: a case report].
Nakamura Y; Murayama K; Katsumi T; Watanabe K; Kishitani M; Ohkawa M
Hinyokika Kiyo; 1994 Aug; 40(8):703-6. PubMed ID: 7942368
[TBL] [Abstract][Full Text] [Related]
15. Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex.
Colaneri M; Quarti A; Pozzi M
Cardiol Young; 2016 Jun; 26(5):1025-8. PubMed ID: 27055516
[TBL] [Abstract][Full Text] [Related]
16. Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors.
Rakowski SK; Winterkorn EB; Paul E; Steele DJ; Halpern EF; Thiele EA
Kidney Int; 2006 Nov; 70(10):1777-82. PubMed ID: 17003820
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
Krischock L; Beach R; Taylor J
Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
[TBL] [Abstract][Full Text] [Related]
18. Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex.
Peces R; Peces C; Cuesta-López E; Pérez-Dueñas V; Vega-Cabrera C; Azorín S; Selgas R
Nephrol Dial Transplant; 2010 Nov; 25(11):3787-91. PubMed ID: 20663789
[TBL] [Abstract][Full Text] [Related]
19. [Bilateral renal angiomyolipoma associated with tuberous sclerosis: conservative surgical treatment].
Millán Serrano JA; Garrón Aoiz L; Montesino Semper M; Santiago González de Garibay AM; Jiménez Calvo J; Idígora Planas X; Sebastián Borruel JL
Arch Esp Urol; 1995; 48(1):87-9. PubMed ID: 7733695
[TBL] [Abstract][Full Text] [Related]
20. Renal angiomyolipoma with intravascular extension into the inferior vena cava: a case report and review of the literature.
Schade GR; Gofrit ON; Zorn KC
Can J Urol; 2008 Apr; 15(2):4012-5. PubMed ID: 18405452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
